Evidence map›Paper›PMID 36878389›Full record

ArticleContemporary clinical trials2023

A protocol for a cluster randomized trial of care delivery models to improve the quality of smoking cessation and shared decision making for lung cancer screening.

Lisa M Lowenstein, Ya-Chen Tina Shih, Jennifer Minnix, Maria A Lopez-Olivo, Kristin G Maki, George Kypriotakis, Viola B Leal, Sanjay S Shete, James Fox, Shawn P Nishi and 2 more

Registry-linked trialOpen access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04200534 (Improving the Quality of Smoking Cessation and Shared Decision Making for Lung Cancer Screening), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04200534 early_phase1active not recruitingnot on this map

Improving the Quality of Smoking Cessation and Shared Decision Making for Lung Cancer Screening: A Cluster Randomized Trial

TypeinterventionalSponsorM.D. Anderson Cancer CenterRan2020 to 2027Enrolled358ConditionsSmoking, Lung CancerArmsBest Practice, Nicotine Patch, Quality-of-Life Assessment, Questionnaire Administration, Tobacco Cessation Counseling
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Updates in Lung Cancer Screening: A Decade of Evidence.Seminars in respiratory and critical care medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lisa M LowensteinDepartments of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: lmlowenstein@mdanderson.org.
Ya-Chen Tina ShihDepartments of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: yashih@mdanderson.org.
Jennifer MinnixBehavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jminnix@mdanderson.org.
Maria A Lopez-OlivoDepartments of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: amlopezo@mdanderson.org.
Kristin G MakiDepartments of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: kmaki@mdanderson.org.
George KypriotakisBehavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: gkypriotakis@mdanderson.org.
Viola B LealDepartments of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sanjay S SheteBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: sshete@mdanderson.org.
James FoxPulmonary & Critical Care Medicine, The University of Texas Health East Texas, Tyler, TX, USA. Electronic address: james.fox@uthct.edu.
Shawn P NishiPulmonary & Critical Care Medicine, The University of Texas Medical Branch, Galveston, TX, USA. Electronic address: spnishi@utmb.edu.
Paul M CinciripiniBehavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: pcinciri@mdanderson.org.
Robert J VolkDepartments of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: bvolk@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USThe University of Texas Health Science Center at Tyler · USThe University of Texas Medical Branch at Galveston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

backgroundPatients eligible for lung cancer screening (LCS) are those at high risk of lung cancer due to their smoking histories and age. While screening for LCS is effective in lowering lung cancer mortality, primary care providers are challenged to meet beneficiary eligibility for LCS from the Centers for Medicare & Medicaid Services, including a patient counseling and shared decision-making (SDM) visit with the use of patient decision aid(s) prior to screening.

methodsWe will use an effectiveness-implementation type I hybrid design to: 1) identify effective, scalable smoking cessation counseling and SDM interventions that are consistent with recommendations, can be delivered on the same platform, and are implemented in real-world clinical settings; 2) examine barriers and facilitators of implementing the two approaches to delivering smoking cessation and SDM for LCS; and 3) determine the economic implications of implementation by assessing the healthcare resources required to increase smoking cessation for the two approaches by delivering smoking cessation within the context of LCS. Providers from different healthcare organizations will be randomized to usual care (providers delivering smoking cessation and SDM on site) vs. centralized care (smoking cessation and SDM delivered remotely by trained counselors). The primary trial outcomes will include smoking abstinence at 12-weeks and knowledge about LCS measured at 1-week after baseline.

conclusionThis study will provide important new evidence about the effectiveness and feasibility of a novel care delivery model for addressing the leading cause of lung cancer deaths and supporting high-quality decisions about LCS. CLINICALTRIALS: GOV PROTOCOL REGISTRATION: NCT04200534

trial registrationClinicalTrials.govNCT04200534.

Indexed as

Lung NeoplasmsSmoking CessationAgedDecision MakingDecision Making, SharedDelivery of Health CareEarly Detection of CancerHumansMedicareRandomized Controlled Trials as TopicUnited StatesCluster-randomized trialEarly detectionEffectiveness-implementation hybrid trialLung neoplasmShared decision-makingSmoking cessation

Identifiers

PMID36878389
PMCPMC10164095
OpenAlexW4323256884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.